Amaconsi e-Eye - eye

"Irifrin" - amaconsi iso, iyisisombululo esicacile, esingenambala noma esiphuzi. Lesi sidakamizwa sinomsebenzi ocacile we-alpha-adrenergic. "Irifrin" amaconsi amaso ayenawo umphumela oshukumisayo ovelayo ohlelweni lomuntu oluphakathi kwenzwa. Lesi sidakamizwa sisetshenziswa phezulu, kubangele ukuqhuma kwezinga lomfundi, ukuphuma kwe-intraocular fluid nokunciphisa izitsha ezihlangene.

"Irifrin" - imiyalo yokusetshenziswa

Lesi sidakamizwa sisekelwe ku-phenylephrine, eshukumisa ama-alpha-adrenoreceptors ama-postsynaptic futhi enomthelela obuthakathaka kuma-beta-adrenoreceptors enhliziyo. "Irifrin" amaconsi amaso anomphumela we-vasoconstrictive, ofanayo nowe-norepinephrine. Ngemuva kokusebenzisa lesi sidakamizwa, umfundi uphuthukisa. Ukuphakama kwe-phenylephrine emathisheni eso kwenzeka ngemva kwemizuzu engu-10-20

Kunconywa ukuba ufake amaconsi "Irifrin" amaconsi amacala alandelayo:

- nge iridocyclitis, ukunciphisa ukukhishwa kwe- iris, kanye nokuvimbela ukubonakala kwe-synechia ehamba phambili;

- ukuqhutshwa komfundi esikoleni lapho kunesidingo sokuhlushwa, ngakho-ke kungenzeka ukuthi ubuyekeze isimo se-back;

- ngenhloso yokwenza uvivinyo oluvusa amadlingozi kulawo maguli anesiprofayili esincane sendawo yekamelo langaphambili noma ukusola kwe-glaucoma ebonakalayo;

- ukuxilongwa ngokungafani kokujola okujulile nokungenangqondo kwe- eyeball ;

- ukwandisa umfundi, ngesikhathi sokubeletha;

- ukuhlinzekwa ngokuvuthwa kwemithi, ngenhloso yokuphucula umfundi, kanye nokwenza umsebenzi nge-laser ku- fundus ;

- ukwelashwa okuyinkimbinkimbi phambi kwezinkinga ze-glaucoma-cyclical;

- ngesikhathi sokubonakala kwe-spasm yokuhlala;

- ukwelashwa kwe-syndrome ye okuthiwa "iso elibomvu", kuyilapho ukusetshenziswa kwalesi sidakamizwa kusiza ukunciphisa ukucasula kwezingqimba zamehlo nama-hypermia.

"Irifrin", amaconsi amehlo - ukuphikisana

Lesi sidakamizwa asikwazi ukusetshenziswa uma isiguli sinesifo esilandelayo:

- ukutholakala kokuthinta okwenziwe okwenziwe emithini eyenza lo muthi;

- isiguli sinesisindo esivaliwe noma i-glaucoma encane-angle;

- Ukusetshenziswa kwezidakamizwa akukhuthazwa kubantu asebekhulile abanezinkinga ezinkulu zesimo senhliziyo noma isisindo somzimba;

- Awunakulisebenzisi lesi sidakamizwa ukuze uphuthukise ngokwengeziwe umfundi ngesikhathi sokuhlinzwa kulawo maguli aphule ubuqotho be-eyeball noma izinkinga zokuqeda;

- ukusetshenziswa kwesisombululo se-10% salesi sidakamizwa kuphikisana nabantwana abangaphansi kweminyaka engu-12 abanesifo esibucayi se-arteries;

Isixazululo se-2.5% sezinsana ezingakabalwa asivumelekile;

- futhi ukusetshenziswa kwezidakamizwa kuyaphikisana phambi kwe-hyperthyroidism, i-hepatic porphyria, ukuntuleka kokuzalwa kwe-glucose-6-phosphate dehydrogenase.

Ngokunakekelwa okukhethekile, kubalulekile ukusebenzisa lesi sidakamizwa kubantu abanesifo sikashukela, abantu asebekhulile. Akudingekile ukuthatha i- "Irifrin" kanye nama- inhibitors we-MAO, ukusetshenziswa okunjalo kungenzeka ngemuva kokuhamba kwezinsuku ezingu-21 kusukela ngesikhathi sokuyeka ukudla kwabo.

Ungadluli umthamo ophakanyisiwe kubantu abanokulimala nezifo zeso noma izinsimbi zalo. Futhi, lesi sidakamizwa asithathwa esikhathini sokuthutha noma phambi kokukhiqizwa kwezinyembezi ezincishisiwe.

Indlela yokusebenza

Ukudala i-mydriasis, kwanele ukwethula ukwehla okukodwa kwe-2.5% "Irifrin" kwisigxobo se- conjunctival. Umphumela ophezulu uyabonwa ngemva kwemizuzu engu-15-30 futhi uhlala emahoreni amathathu. Uma isisombululo se-2.5% asanele, khona-ke izingane ezingaphezu kweminyaka engu-12 ubudala, kanye neziguli ezikhulile, kungenzeka ukusebenzisa isisombululo se-10% kumanani afanayo.